ClinicalTrials.gg
Sign In

Central Nervous System Diseases clinical trials

The registry lists 386 studies for Central Nervous System Diseases across more than 10 countries. 104 are recruiting or about to start. 32 of them are mainly about Central Nervous System Diseases (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-12. Counting its 204 narrower conditions too, such as Stroke: 47,519 studies, 11,317 open.

Get an email when these change. Save the Central Nervous System Diseases studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
193
Recruiting
75
Terminated
29
Status unknown
25
Not yet recruiting
20
Active, not recruiting
17

Phase

Phase 2
102
Phase 1
58
Phase 3
45
Phase 4
9
Early Phase 1
1

Where

United States
193
France
46
Canada
42
Germany
41
Spain
38
Italy
31

Who runs them

National Institute of Allergy and Infectious Diseases (NIAID) (6) · M.D. Anderson Cancer Center (5) · Eli Lilly and Company (5) · Novartis (5) · Tammie L. S. Benzinger, MD, PhD (5) · Bracco Diagnostics, Inc (4) · Washington University School of Medicine (4) · Danish Headache Center (4)

What is being tested here

Drugs under test in Central Nervous System Diseases studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
ML-007C304
Testosterone212
Islet Amyloid Polypeptide202
Bevacizumab102
Tenecteplase112
Finasteride112
Testosterone 17 beta-cypionate111
Tislelizumab101
Capecitabine101
Nicotinamide-beta-riboside101

Drug classes tested here Tyrosine kinase inhibitors (TKIs) 1 open · Dopamine agonists 7 · Antipsychotics 4

Coming up

10phase 3 studies under way
31studies finish main data collection within a year1 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 75 Central Nervous System Diseases studies recruiting now, 34 (45%) set no upper age limit and 21 (28%) stop at 75 or younger. 10 (13%) take children under 18. 4 (5%) are for women only and 2 (3%) for men only; 12 (16%) take healthy volunteers.

Recruiting studies that take each age, of 75
AgeWomenMen
108 (11%)8 (11%)
1851 (68%)51 (68%)
3052 (69%)52 (69%)
4057 (76%)57 (76%)
5062 (83%)62 (83%)
6566 (88%)66 (88%)
7561 (81%)61 (81%)
8545 (60%)45 (60%)

Across all 386 studies, recruiting or not: 29% stop at 75 or younger and 20% at 65; 18% take children; 2% are for women only and 2% for men only; 13% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Central Nervous System Diseases studies take

Of 37 phase 2 interventional studies under Central Nervous System Diseases, half reached primary completion within 28 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 124 mo7–45 · 20 studies——
Phase 228 mo22–44 · 37 studies——
Phase 340 mo21–56 · 17 studies——
Interventional, no phase38 mo17–58 · 88 studies—39 mo17–58 · 77 studies
Observational67 mo22–121 · 39 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 13, 2026.

Newly registered4

Studies

Recruiting first, then most recently updated. Showing 50 of 386. Browse all 386 → or search them.